AusculSciences Announces First Customer for COVID-19 Innovation

Company’s remote, disposable stethoscope will be purchased and tested by the Government of Canada.

OTTAWA, CANADA – August 12, 2020 – AusculSciences™, a pioneer in developing advanced acoustic technologies to detect cardiovascular and pulmonary conditions, today announced that the Government of Canada will purchase and evaluate its Auscul-X™ Touchless Stethoscope System.  Auscul-X is a remote, disposable stethoscope which allows physicians and nurses to listen to heart and lung sounds from outside the patient’s room, helping to keep healthcare professionals at a safe distance from patients with diagnosed or suspected infectious diseases, such as COVID-19, and allowing them to conserve PPE.  Protecting the health and safety of frontline healthcare workers is one of the 5 priorities identified by the Canadian Medical Association (CMA) to prepare for a potential COVID-19 resurgence.

The company has been awarded a contract under the Innovative Solutions Canada program whereby the Canadian Special Operations Forces Command will test Auscul-X on patient simulators as well as human volunteers.

Over 10% of those infected with COVID-19 are healthcare professionals.  Auscul-X provides nurses and physicians the ability to listen to and visualize the sounds of a patient’s heart, lungs, and other internal organs from outside the patient’s room, thereby reducing their exposure to infectious diseases such as COVID-19 and allowing them to conserve PPE.  More information about Auscul-X can be found at www.ausculsciences.com/auscul-x.

Auscul-X has been authorized by Health Canada for investigational use, and the company expects it to be on-market in late 2020.  Auscul-X will also be evaluated on critical care patients in an investigator-led study at the University of Ottawa Heart Institute beginning later this month.

About AusculSciences

AusculSciences is a medical device, services, and software solutions company dedicated to the development of acoustic technologies to detect cardiovascular and pulmonary conditions.  AusculSciences’ innovative approach provides physicians and nurses with actionable data to support clinical decision making, reduce the cost of diagnoses while improving patient care and provider safety.

For more information, contact:

John Phillips
Vice President, Business Development
AusculSciences
Tel: +1-613-763-0088 ext. 102
Email: john@ausculsciences.com
Twitter: @ausculsciences